• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎变异株的传染性排出时间及其与症状的关系。

Duration of infectious shedding of SARS-CoV-2 Omicron variant and its relation with symptoms.

机构信息

Department of Infectious Diseases and Clinical Microbiology, Koç University School of Medicine, Istanbul, Turkey; Koç University-Isbank Center for Infectious Diseases, Turkey.

Koç University-Isbank Center for Infectious Diseases, Turkey.

出版信息

Clin Microbiol Infect. 2023 Feb;29(2):221-224. doi: 10.1016/j.cmi.2022.07.009. Epub 2022 Jul 16.

DOI:10.1016/j.cmi.2022.07.009
PMID:35853589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9287585/
Abstract

OBJECTIVES

SARS-CoV-2 infections with Omicron variants have a high capability of human-to-human transmission. Nevertheless, the duration of isolation for mild cases was shortened to 5 to 7 days. We aimed to detect the duration of viral shedding among healthcare workers (HCWs) with Omicron by using viral culture.

METHODS

We prospectively included newly diagnosed nonsevere, symptomatic SARS-CoV-2 positive HCWs. Nasopharyngeal swab samples were obtained consecutively on days 5, 7,10, and 14 of onset of symptoms. The samples were examined by nucleic acid amplification test and viral culture.

RESULTS

In total, 55 non-severe patients with SARS-CoV-2 Omicron variant were included. The mean age of the population was 34 years (range, 23 to 54) and 78% (43/55) were female. The PCR positivity rate on days 5, 7, 10, and 14 was 96.4% (53/55), 87.3% (48/55), 74.545% (41/55), and 41.8% (23/55) consecutively, whereas the viral culture positivity rates were 83% (44/53), 52% (26/50), 13.5% (7/52), and 8% (4/50). Among the patients who became symptom-free, the viral culture positivity rates were 100% (4/4), 58% (7/12), 11% (3/27), and 5% (2/41).

DISCUSSION

We showed that among the SARS-CoV-2 Omicron variant infected patients, viral shedding continues for ≥10 days in 13.5% of all cases and 11% in symptom-free cases. The decision for cessation of isolation according to the presence of symptoms could be reconsidered until further studies disapprove of our results. Meanwhile, the infected HCWs who give care to high-risk patients for severe COVID-19 might extend their isolations ≤10 days after the onset of symptoms, regardless of their symptoms.

摘要

目的

感染奥密克戎变异株的 SARS-CoV-2 具有很强的人际传播能力。然而,轻度病例的隔离时间已缩短至 5 至 7 天。我们旨在通过病毒培养检测奥密克戎变异株感染的医护人员 (HCWs) 的病毒脱落持续时间。

方法

我们前瞻性纳入新诊断的非重症、有症状的 SARS-CoV-2 阳性 HCWs。在症状出现的第 5、7、10 和 14 天连续采集鼻咽拭子样本。使用核酸扩增试验和病毒培养法检测样本。

结果

共纳入 55 例非重症 SARS-CoV-2 奥密克戎变异株感染患者。人群平均年龄为 34 岁(范围,23 至 54 岁),78%(43/55)为女性。第 5、7、10 和 14 天的 PCR 阳性率分别为 96.4%(53/55)、87.3%(48/55)、74.545%(41/55)和 41.8%(23/55),病毒培养阳性率分别为 83%(44/53)、52%(26/50)、13.5%(7/52)和 8%(4/50)。在症状缓解的患者中,病毒培养阳性率分别为 100%(4/4)、58%(7/12)、11%(3/27)和 5%(2/41)。

讨论

我们发现,在奥密克戎变异株感染患者中,所有病例中有 13.5%、无症状病例中有 11%的病毒脱落持续时间≥10 天。根据症状决定停止隔离的决定可能需要重新考虑,直到进一步的研究证明我们的结果不可靠。同时,对于照顾 COVID-19 重症高危患者的感染 HCWs,无论症状如何,在症状出现后 10 天内可能需要延长隔离时间。

相似文献

1
Duration of infectious shedding of SARS-CoV-2 Omicron variant and its relation with symptoms.奥密克戎变异株的传染性排出时间及其与症状的关系。
Clin Microbiol Infect. 2023 Feb;29(2):221-224. doi: 10.1016/j.cmi.2022.07.009. Epub 2022 Jul 16.
2
Duration of viable virus shedding and polymerase chain reaction positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract: a systematic review and meta-analysis.奥密克戎变异株在上呼吸道存活病毒和聚合酶链反应阳性的持续时间:系统评价和荟萃分析。
Int J Infect Dis. 2023 Apr;129:228-235. doi: 10.1016/j.ijid.2023.02.011. Epub 2023 Feb 18.
3
Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study.新冠病毒感染后症状患者中,新冠病毒(SARS-CoV-2)的病毒动力学:对香港感染原始株和奥密克戎 BA.2 患者的回顾性观察研究。
Lancet Microbe. 2023 Sep;4(9):e722-e731. doi: 10.1016/S2666-5247(23)00146-5.
4
An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA.解除对 SARS-CoV-2 RNA 持续排出的医护人员的自我隔离的方法。
Infection. 2021 Feb;49(1):95-101. doi: 10.1007/s15010-020-01530-4. Epub 2020 Oct 6.
5
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections.在原始或奥密克戎 BA.1 SARS-CoV-2 感染期间的病毒脱落动力学,以及在突破感染期间增强预先存在的免疫。
Emerg Microbes Infect. 2022 Dec;11(1):2423-2432. doi: 10.1080/22221751.2022.2122578.
6
Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.无症状 SARS-CoV-2 携带者病毒的脱落。
mSphere. 2021 May 19;6(3):e00019-21. doi: 10.1128/mSphere.00019-21.
7
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.奥密克戎变异株感染者的传染性病毒脱落持续时间。
Emerg Infect Dis. 2022 May;28(5):998-1001. doi: 10.3201/eid2805.220197. Epub 2022 Mar 15.
8
Clinical characteristics and risk factors analysis of viral shedding time in mildly symptomatic and asymptomatic patients with SARS-CoV-2 Omicron variant infection in Shanghai.上海地区 SARS-CoV-2 奥密克戎变异株感染轻症和无症状患者病毒脱落时间的临床特征及影响因素分析。
Front Public Health. 2023 Jan 4;10:1073387. doi: 10.3389/fpubh.2022.1073387. eCollection 2022.
9
Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.持续的 SARS-CoV-2 RNA 脱落而无传染性证据:一项 COVID-19 患者的队列研究。
J Infect Dis. 2021 Oct 28;224(8):1362-1371. doi: 10.1093/infdis/jiab107.
10
Kinetics of Viral Shedding for Outbreak Surveillance of Emerging Infectious Diseases: Modeling Approach to SARS-CoV-2 Alpha and Omicron Infection.用于新发传染病暴发监测的病毒脱落动力学:SARS-CoV-2 Alpha 和 Omicron 感染的建模方法。
JMIR Public Health Surveill. 2024 Sep 19;10:e54861. doi: 10.2196/54861.

引用本文的文献

1
SARS-CoV-2 bioaerosol transmission in experimentally infected American mink.严重急性呼吸综合征冠状病毒2在实验感染的美国水貂中的生物气溶胶传播
Sci Rep. 2025 Jul 1;15(1):22270. doi: 10.1038/s41598-025-08111-1.
2
Uncertainty in COVID-19 transmission could undermine our ability to predict long COVID.新冠病毒传播的不确定性可能会削弱我们预测长期新冠的能力。
J R Soc Interface. 2024 Dec;21(221):20240438. doi: 10.1098/rsif.2024.0438. Epub 2024 Dec 11.
3
A tight fit of the SIR dynamic epidemic model to daily cases of COVID-19 reported during the 2021-2022 Omicron surge in New York City: A novel approach.

本文引用的文献

1
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.奥密克戎变异株感染者的传染性病毒脱落持续时间。
Emerg Infect Dis. 2022 May;28(5):998-1001. doi: 10.3201/eid2805.220197. Epub 2022 Mar 15.
2
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.比较 COVID-19 疫苗在针对 SARS-CoV-2 及其关注变异株的特性、疗效和有效性方面的差异:一项叙述性综述。
Clin Microbiol Infect. 2022 Feb;28(2):202-221. doi: 10.1016/j.cmi.2021.10.005. Epub 2021 Oct 27.
3
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study.
将 SIR 动态传染病模型与 2021-2022 年在纽约市奥密克戎疫情期间报告的每日 COVID-19 病例进行紧密拟合:一种新方法。
Stat Methods Med Res. 2024 Oct;33(10):1877-1898. doi: 10.1177/09622802241277956.
4
Modeling the Impact of Ensitrelvir on SARS-CoV-2 Dynamics and Its Application for Assessment of Transmission Mitigation of Patients with COVID-19.恩昔瑞韦对严重急性呼吸综合征冠状病毒2动力学的影响建模及其在评估2019冠状病毒病患者传播缓解中的应用
Infect Dis Ther. 2024 Nov;13(11):2377-2393. doi: 10.1007/s40121-024-01046-6. Epub 2024 Oct 7.
5
Surveillance of respiratory viruses by aerosol screening in indoor air as an early warning system for epidemics.通过气溶胶筛查监测室内空气中的呼吸道病毒,作为传染病的预警系统。
Environ Microbiol Rep. 2024 Aug;16(4):e13303. doi: 10.1111/1758-2229.13303.
6
A retrospective analysis of the influencing factors of nucleic acid CT value fluctuation in COVID-19 patients infected with Omicron variant virus in Changchun city.长春市感染奥密克戎变异株的新冠病毒患者核酸 CT 值波动影响因素的回顾性分析。
Front Public Health. 2024 Jun 14;12:1377135. doi: 10.3389/fpubh.2024.1377135. eCollection 2024.
7
Duration of SARS-CoV-2 shedding: A systematic review.SARS-CoV-2 排毒持续时间:系统综述。
J Glob Health. 2024 Mar 29;14:05005. doi: 10.7189/jogh.14.05005.
8
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.非住院的成年人感染 SARS-CoV-2 亚变体奥密克戎 BA.1、BA.2、BA.4/5 或德尔塔导致的 COVID-19,无论其疫苗接种史如何,其疾病持续时间、症状严重程度和病毒动力学均相似。
PLoS One. 2024 Mar 21;19(3):e0294897. doi: 10.1371/journal.pone.0294897. eCollection 2024.
9
The evaluation of a rapid microfluidic immunofluorescence antigen test in detecting the infectiousness of COVID-19 patients.快速微流控免疫荧光抗原检测评估新冠病毒感染者的传染性。
BMC Infect Dis. 2023 Nov 23;23(1):823. doi: 10.1186/s12879-023-08821-9.
10
Coffee as a dietary strategy to prevent SARS-CoV-2 infection.咖啡作为预防新型冠状病毒感染的饮食策略。
Cell Biosci. 2023 Nov 14;13(1):210. doi: 10.1186/s13578-023-01154-9.
有症状的疑似 COVID-19 医护人员的临床和实验室特征:一项前瞻性队列研究。
Sci Rep. 2021 Jul 22;11(1):14977. doi: 10.1038/s41598-021-93828-y.
4
Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis.新冠病毒感染中病毒脱落时间特征:系统评价和荟萃分析。
Front Public Health. 2021 Mar 19;9:652842. doi: 10.3389/fpubh.2021.652842. eCollection 2021.
5
Severe covid-19 pneumonia: pathogenesis and clinical management.严重 COVID-19 肺炎:发病机制与临床管理。
BMJ. 2021 Mar 10;372:n436. doi: 10.1136/bmj.n436.